The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Patients with high‐risk neuroblastoma (HR NBL) treated with myeloablative regimens are reported to be at risk for cardiovascular morbidity, and this risk may be increased by impaired renal function.
Procedure
Long‐term renal function was assessed in a national cohort of 18 (age 22.4 ± 4.9 years) HR NBL survivors by plasma creatinine (P‐Cr), urea, and cystatin C (P‐Cys C) concentrations,...
BackgroundThe aim of the study was to evaluate arterial morphology and function in a national cohort of long‐term survivors of high‐risk neuroblastoma (NBL) treated with high‐dose chemotherapy and autologous hematopoietic stem cell transplantation with or without total body irradiation (TBI).
Methods and ResultsCommon carotid, femoral, brachial, and radial artery morphology were assessed with very‐high‐resolution...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.